• Home
  • Contact Us
  • Try it!
  • Graphs
  • Publications
  • Blog

Follow us

Recent Posts

  • Biovista Vizit New Corpus: ClinicalTrials.gov September 16, 2025
  • Biovista Vizit New Corpus: MATISSE (a SoftMining algorithm) May 13, 2025
  • Biovista Vizit New Corpus: HPO March 4, 2025
  • Biovista Vizit January 2025 Release – AOP Features January 30, 2025
  • Uberon OBO Contribution May 22, 2024

Biovista Vizit

Biovista Vizit

  • Try it!
  • Graphs
  • Publications
  • Blog

Immune checkpoint blockade in cancer immunotherapy

August 28, 2018Cancer, Cancer Immunotherapy, Vizit Graphs
Immune checkpoint blockade in cancer immunotherapyChristos Andronis2020-08-03T13:49:12-04:00
Immune checkpoint blockade in cancer immunotherapy

Explore immune checkpoint blockade (PD-1, CTLA-4) in cancer immunotherapy with Biovista Vizit.

Explore the live graph.

Tags: ABATACEPT, CANCER, CTLA4, CYTOKINE PRODUCTION, IMMUNE RESPONSE, IPILIMUMAB, LYMPHOCYTE ACTIVATION, MELANOMA, NIVOLUMAB, PD-1, PEMBROLIZUMAB, PROGRAMMED CELL DEATH, REGULATORY T-LYMPHOCYTES, T CELL ACTIVATION

Post navigation

← Circadian rhythm genes
Drugs for Parkinson’s and Alzheimer’s →
TAUOPATHIES VITAMIN D VEGFA TMPRSS2 THY-1 ANTIGENS VEGF TAU THROMBOCYTOPENIA TROPISM TRANSLATION TP53 UCHL1 PROTEIN VGF PROTEIN TISSUE DEVELOPMENT TUMOR GROWTH VASODILATION TIMELESS Uberon TUMOR PROGRESSION TRACHEA VIRUS DISEASES TROGLITAZONE THROMBOSIS TH17 CELLS TYPE 2 DIABETES TREPONEMA DENTICOLA UBIQUITINATION TGF-BETA TRANSPORT VIRAL RELEASE FROM HOST CELL THORAX TECFIDERA THROMBIN TUMOR VEINS TARGET LESION IDENTIFICATION VASOCONSTRICTION X-RAY COMPUTED TOMOGRAPHY ULCERATIVE COLITIS WOUND HEALING VASCULAR VERO CELLS TRASTUZUMAB

© 2025 Biovista Vizit All Rights Reserved.

Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}